Ubs Group Ag Emergent Bio Solutions Inc. Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Ubs Group Ag holds 590,221 shares of EBS stock, worth $4.41 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
590,221
Previous 268,438
119.87%
Holding current value
$4.41 Million
Previous $2.24 Million
151.76%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding EBS
# of Institutions
173Shares Held
36.8MCall Options Held
336KPut Options Held
203K-
Black Rock Inc. New York, NY3.84MShares$28.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.2MShares$23.9 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.14MShares$16 Million0.01% of portfolio
-
State Street Corp Boston, MA1.96MShares$14.7 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.54MShares$11.5 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $373M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...